EP1220936A2 - Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire - Google Patents
Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaireInfo
- Publication number
- EP1220936A2 EP1220936A2 EP00965435A EP00965435A EP1220936A2 EP 1220936 A2 EP1220936 A2 EP 1220936A2 EP 00965435 A EP00965435 A EP 00965435A EP 00965435 A EP00965435 A EP 00965435A EP 1220936 A2 EP1220936 A2 EP 1220936A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- expression
- plant
- promoter
- construct
- expression construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 240000008042 Zea mays Species 0.000 title claims description 57
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims description 50
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 title claims description 41
- 235000009973 maize Nutrition 0.000 title claims description 41
- 230000022131 cell cycle Effects 0.000 title description 21
- 108700005075 Regulator Genes Proteins 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 91
- 230000014509 gene expression Effects 0.000 claims abstract description 90
- 230000032823 cell division Effects 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 47
- 108090000266 Cyclin-dependent kinases Proteins 0.000 claims abstract description 38
- 102000003903 Cyclin-dependent kinases Human genes 0.000 claims abstract description 34
- 230000009261 transgenic effect Effects 0.000 claims abstract description 18
- 230000002708 enhancing effect Effects 0.000 claims abstract description 14
- 108091007914 CDKs Proteins 0.000 claims abstract description 12
- 210000000056 organ Anatomy 0.000 claims abstract description 12
- 230000001850 reproductive effect Effects 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 188
- 210000004027 cell Anatomy 0.000 claims description 66
- 102000016736 Cyclin Human genes 0.000 claims description 36
- 108050006400 Cyclin Proteins 0.000 claims description 34
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
- 239000002773 nucleotide Substances 0.000 claims description 19
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 230000001105 regulatory effect Effects 0.000 claims description 17
- 238000011161 development Methods 0.000 claims description 15
- 230000018109 developmental process Effects 0.000 claims description 15
- 230000010152 pollination Effects 0.000 claims description 14
- 230000001939 inductive effect Effects 0.000 claims description 13
- 230000002123 temporal effect Effects 0.000 claims description 13
- 101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 claims description 10
- 101000580039 Homo sapiens Ras-specific guanine nucleotide-releasing factor 1 Proteins 0.000 claims description 10
- 102100023330 M-phase inducer phosphatase 3 Human genes 0.000 claims description 10
- 241000209140 Triticum Species 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 230000002068 genetic effect Effects 0.000 claims description 9
- 241000219194 Arabidopsis Species 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 7
- 230000001965 increasing effect Effects 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 6
- 235000007164 Oryza sativa Nutrition 0.000 claims description 6
- 235000009566 rice Nutrition 0.000 claims description 6
- 229920002494 Zein Polymers 0.000 claims description 5
- 230000003698 anagen phase Effects 0.000 claims description 5
- 239000005019 zein Substances 0.000 claims description 5
- 229940093612 zein Drugs 0.000 claims description 5
- 240000006394 Sorghum bicolor Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 230000001976 improved effect Effects 0.000 claims description 2
- 210000005132 reproductive cell Anatomy 0.000 claims description 2
- 101150058089 LTP2 gene Proteins 0.000 claims 3
- 230000008774 maternal effect Effects 0.000 claims 3
- 238000003259 recombinant expression Methods 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract description 8
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 230000007613 environmental effect Effects 0.000 abstract description 4
- 244000038559 crop plants Species 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 35
- 210000001519 tissue Anatomy 0.000 description 29
- 230000009466 transformation Effects 0.000 description 26
- 230000035882 stress Effects 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 15
- 239000013604 expression vector Substances 0.000 description 11
- 239000003550 marker Substances 0.000 description 11
- 230000026731 phosphorylation Effects 0.000 description 11
- 238000006366 phosphorylation reaction Methods 0.000 description 11
- 241000206602 Eukaryota Species 0.000 description 10
- 239000013598 vector Substances 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000053187 Glucuronidase Human genes 0.000 description 7
- 108010060309 Glucuronidase Proteins 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 108091033319 polynucleotide Proteins 0.000 description 7
- 102000040430 polynucleotide Human genes 0.000 description 7
- 239000002157 polynucleotide Substances 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 6
- 101710196810 Non-specific lipid-transfer protein 2 Proteins 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- 108700008625 Reporter Genes Proteins 0.000 description 5
- 108700021031 cdc Genes Proteins 0.000 description 5
- 210000005069 ears Anatomy 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 4
- 208000005156 Dehydration Diseases 0.000 description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 108060001084 Luciferase Proteins 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- 108700019146 Transgenes Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 description 4
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 4
- 239000004062 cytokinin Substances 0.000 description 4
- 230000030609 dephosphorylation Effects 0.000 description 4
- 238000006209 dephosphorylation reaction Methods 0.000 description 4
- 239000005090 green fluorescent protein Substances 0.000 description 4
- 239000004009 herbicide Substances 0.000 description 4
- 230000008121 plant development Effects 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 102000003910 Cyclin D Human genes 0.000 description 3
- 108090000259 Cyclin D Proteins 0.000 description 3
- 239000005089 Luciferase Substances 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 108050002653 Retinoblastoma protein Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 230000036579 abiotic stress Effects 0.000 description 3
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 108010050181 aleurone Proteins 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 108010072268 cyclin-dependent kinase-activating kinase Proteins 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000008641 drought stress Effects 0.000 description 3
- 230000004577 ear development Effects 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000003630 growth substance Substances 0.000 description 3
- 230000002363 herbicidal effect Effects 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000022983 regulation of cell cycle Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 2
- 241000207875 Antirrhinum Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- 101000945286 Drosophila melanogaster Serine/threonine-protein kinase PITSLRE Proteins 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 2
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 2
- 230000018199 S phase Effects 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 108020002494 acetyltransferase Proteins 0.000 description 2
- 102000005421 acetyltransferase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000025084 cell cycle arrest Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000021759 endosperm development Effects 0.000 description 2
- 108010050792 glutenin Proteins 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 239000003375 plant hormone Substances 0.000 description 2
- 230000037039 plant physiology Effects 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000006916 protein interaction Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000031539 regulation of cell division Effects 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000008117 seed development Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 1
- 101710140048 2S seed storage protein Proteins 0.000 description 1
- UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101001004809 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 1 Proteins 0.000 description 1
- 101001004810 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 2 Proteins 0.000 description 1
- 101001004812 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 3 Proteins 0.000 description 1
- 101001004814 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 4 Proteins 0.000 description 1
- 101001004816 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 5 Proteins 0.000 description 1
- 101001004818 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 6 Proteins 0.000 description 1
- 101001004820 Arabidopsis thaliana Leucine-rich repeat extensin-like protein 7 Proteins 0.000 description 1
- 101001067239 Arabidopsis thaliana Pollen-specific leucine-rich repeat extensin-like protein 1 Proteins 0.000 description 1
- 101001067237 Arabidopsis thaliana Pollen-specific leucine-rich repeat extensin-like protein 2 Proteins 0.000 description 1
- 101001067254 Arabidopsis thaliana Pollen-specific leucine-rich repeat extensin-like protein 3 Proteins 0.000 description 1
- 101001067253 Arabidopsis thaliana Pollen-specific leucine-rich repeat extensin-like protein 4 Proteins 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101150012716 CDK1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000042795 Colotes Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 101710091838 Convicilin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 101100457919 Drosophila melanogaster stg gene Proteins 0.000 description 1
- 108010093502 E2F Transcription Factors Proteins 0.000 description 1
- 102000001388 E2F Transcription Factors Human genes 0.000 description 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
- 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 230000004668 G2/M phase Effects 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 108700005087 Homeobox Genes Proteins 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 101000966481 Mus musculus Dihydrofolate reductase Proteins 0.000 description 1
- 101000875535 Nicotiana tabacum Extensin Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 108010047620 Phytohemagglutinins Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010043400 Protamine Kinase Proteins 0.000 description 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 102100038042 Retinoblastoma-associated protein Human genes 0.000 description 1
- 101710124357 Retinoblastoma-associated protein Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 101710196023 Vicilin Proteins 0.000 description 1
- 101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 108010083912 bleomycin N-acetyltransferase Proteins 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- HOZOZZFCZRXYEK-GSWUYBTGSA-M butylscopolamine bromide Chemical compound [Br-].C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3[N+]([C@H](C2)[C@@H]2[C@H]3O2)(C)CCCC)=CC=CC=C1 HOZOZZFCZRXYEK-GSWUYBTGSA-M 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 101150069072 cdc25 gene Proteins 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008126 female flower development Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 108010083391 glycinin Proteins 0.000 description 1
- 210000004397 glyoxysome Anatomy 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000009001 hormonal pathway Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 101150024228 mdm2 gene Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 210000000473 mesophyll cell Anatomy 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000021232 nutrient availability Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 101150113864 pat gene Proteins 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 230000001885 phytohemagglutinin Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000020978 protein processing Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028617 response to DNA damage stimulus Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000034655 secondary growth Effects 0.000 description 1
- 230000035040 seed growth Effects 0.000 description 1
- 230000005562 seed maturation Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 108010008664 streptomycin 3''-kinase Proteins 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 230000006032 tissue transformation Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001478887 unidentified soil bacteria Species 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- This invention relates generally to the field of plant molecular biology. More specifically, this invention relates to methods and reagents for the temporal and spatial expression of genes that enhance cell division in plants, especially transgenic plants, to increase yield and health of crop plants in general as well as in periods of stress.
- Cell division plays a crucial role during all phases of plant development.
- the continuation of organogenesis and growth responses to a changing environment require precise spatial, temporal and developmental regulation of cell division activity in meristems (and in cells with the capability to form new meristems, such as in lateral root formation).
- Control of cell division is also important in organs themselves (i.e., separate from meristems per se), for example, in leaf expansion, secondary growth, and endoreduplication.
- a complex network controls cell division in eukaryotes.
- Various regulatory pathways communicate environmental constraints such as nutrient availability, mitogenic signals such as growth factors or hormones, or developmental cues such as the transition from vegetative to reproductive growth. Ultimately, these regulatory pathways control the timing, rate, plane, and position of cell division.
- Cell division in higher eukaryotes is controlled by two main checkpoints in the cell cycle which prevent the cell from entering either M- or S-phase prematurely.
- Evidence from yeast and mammalian systems has repeatedly shown that over-expression of key cell cycle genes can either trigger cell division in non- dividing cells, or stimulate division in previously dividing cells (i.e., the duration of the cell cycle is decreased and cell size is reduced). Examples of genes whose over-expression has been shown to stimulate cell division include cyclins (see, e.g.,
- the basic mechanism of cell cycle control is conserved among eukaryotes.
- a catalytic protein kinase and an activating cyclin subunit control progress through the cell cycle.
- the protein kinase is generally referred to as a cyclin - dependent-kinase (CDK), whose activity is modulated by phosphorylation and dephosphorylation events and by association with regulatory subunits called cyclins.
- CDKs require association with cyclins for activation, and the timing of activation is largely dependent upon cyclin expression.
- Eukaryote genomes typically encode multiple cyclin and CDK genes. In higher eukaryotes, different members of the CDK family act in different stages of the cell cycle.
- Cyclin genes are classified according to the timing of their appearance during the cell cycle.
- CDKs are often physically associated with other proteins which alter localization, substrate specificity, or activity.
- CDK interacting proteins are the CDK inhibitors, members of the Retinoblastoma-associated protein (Rb) family, and the Constitutive Kinase Subunit (CKS).
- the protein kinase activity of the complex is regulated by feedback control at certain checkpoints. At such checkpoints the CDK activity becomes limiting for further progress. When the feedback control network senses the completion of a checkpoint, CDK is activated and the cell passes through to the next checkpoint. Changes in CDK activity are regulated at multiple levels, including reversible phosphorylation of the cell cycle factors, changes in subcellular localization of the complex, and the rates of synthesis and destruction of limiting components. Regulation of the cell cycle by the cyclin/CDK complex is noted particularly at the
- Plants have unique developmental features that distinguish them from other eukaryotes. Plant cells do not migrate, and thus only cell division, expansion, and programmed cell death determine morphogenesis. Organs are formed throughout the entire life span of the plant from specialized regions called meristems. In addition, many differentiated cells have the potential both to dedifferentiate and to reenter the cell cycle. There are also numerous examples of plant cell types that undergo endoreduplication, a process involving nuclear multiplication without cytokinesis. The study of plant cell cycle control genes is expected to contribute to the understanding of these unique phenomena. O. Shaul et al., Regulation of Cell Division in Arabidopsis, Critical Reviews in Plant Sciences, 15(2):97-112 (1996).
- Anthesis is generally recognized as the critical period of ear and kernel development in maize. Varied experimental approaches demonstrate that treatments, which decrease the cell division around anthesis, decrease grain yield. For example, large yield losses occur when maize plants are subjected to abscisic acid (ABA) (Myers, P.N. et al, 1990; Mambelli and Setter, 1998), thermal stress (Jones, R.J. et al, 1985; Cheikh and Jones, 1994), water-deficits (Artlip, T.S. et al, 1995) or exposed to high plant density around anthesis. (See Zinselmeier, C. and J.E.
- ABA abscisic acid
- kernel number and size may be limited by cell division, particularly during drought or high density stress at anthesis.
- enhancing cell division of the immature ear and grain would maintain ear and seed growth, and as a consequence, buffer this important vulnerable period of yield formation.
- the tissues targeted for transgenes are in the maize female inflorescence, since relative to other organs, it is frequently the most sensitive to abiotic stress.
- transient water stress prior to pollination has been shown to arrest the growth of ears, embryo sacs, and silks.
- drought stress can inhibit endosperm cell division, which peaks at 8 to 10 days after pollination.
- both kernel set and endosperm development are inhibited. This effect is most pronounced in the apical region of the ear.
- Retarded endosperm development can result in aborted apical kernels, because of reduced cell division and decreased endoreduplication.
- both of these events have been shown to be controlled by cyclin dependent protein kinases.
- Barrennesss (the lack of ear development) is one of the most common manifestations of maize plants grown at high densities. Another prevalent trait in density stressed plants is an increase in the anthesis/silking interval, which has been shown to be the result of retarded ear growth. Based on this and other information, one key to producing a viable ear under plant-population stress is to maintain its growth rate. Since cell division is a key component of organ growth, the cell cycle regulatory mechanism in the female inflorescence is the target for expression of transgenes.
- the present invention comprises the spatial and temporal expression of a nucleotide sequence which will enhance stress tolerance (buffer female inflorescence), particularly high density and drought stresses, in plants at critical times in plant development such as the vulnerable time of anthesis.
- this invention relates to polynucleotides which encode proteins involved in the regulation of the cell cycle. More particularly, the polynucleotides encode proteins which enhance cell division in maize ears and kernels by directly increasing the activities of cyclin dependent protein kinases or indirectly by augmenting the activity of enzymes which control CDK activity.
- Cell division in higher eukaryotes is controlled by a well-conserved mechanism.
- the principal control factor of this mechanism is a protein threonine/serine kinase complex that is composed of cyclin (the regulatory subunit) and CDK (the catalytic subunit).
- This complex controls cell division by phosphorylating target proteins.
- Eukaryotes have evolved an elaborate regulatory network to safeguard the fluctuation of CDK activities in the cell cycle. Cyclins oscillate in abundance as a result of both transcriptional and post- transcriptional regulation. This provides an on/off control for CDK, since the association of cyclin is absolutely required for kinase activity. Phosphorylation and dephosphorylation of CDK occurs.
- CDK activating kinase activates CDK
- phosphorylation of Thrl4 and Tyrl ⁇ by Mytl and Weel respectively, inactivates CDK
- CDC25 a protein tyrosine phosphatase dephosphorylates Tyrl ⁇ and activates CDK (Kumagai, A. and Dunphy, W.G., Cell 70, 139 (1992).
- Both Weel and CDC25 are in turn regulated by phosphorylation.
- Niml a protein kinase identified in S. pombe is able to phosphorylate Weel (this inhibits Weel activity), while Plxl is able to use CDC25 as a substrate and enhance CDC25 activity, a positive feedback loop for CDK regulation.
- the CDK complex interacts with CDK inhibitors (CKIs).
- CKIs CDK inhibitors
- a number of proteins can physically bind to CDK and inhibit CDK activity.
- Well- characterized inhibitors in human systems include p21, p27, p57, pl6, and pl9. Identification of rate-limiting pathways influenced by abiotic stresses are important in determining which ones to target.
- Apical kernel abortion is a common characteristic of maize subjected to drought stress.
- Research has shown that the plant hormone cytokinin, is able to reduce apical kernel abortion. Concurrently, it was shown that cytokinin can enhance CDK activities by reducing the extent of CDK phosphorylation at Tyrl ⁇ .
- Other research has shown that the cell cycle regulatory mechanism is highly conserved among all eukaryotes. Cell cycle genes from maize, Arabidopsis, and alfalfa are able to rescue yeast mutants that are defective in cell cycle genes. Likewise, yeast cell cycle genes, such as CDC25, are able to promote cell division in higher plants. Thus, heterologous genes will work in transgenic maize events.
- the invention comprises a genetic construct which upon expression in plant cells provides a DNA sequence encoding a gene product useful for directing the phosphorylation or activation state of CDK of a plant or plant tissue. Particularly, B-type and D-type cyclins, CDC25, Niml, and Plxl will be over expressed in order to promote cell division under stress.
- the invention comprises a genetic construct which provides a DNA sequence encoding a gene product useful for co-suppressing Weel in order to promote cell division of a plant or plant tissue. Kernel abortion increases when unfavorable environments occur around flowering, thereby decreasing genetic yield potential in plants.
- CDKs are critical enzymes that determine maize floral cell division. Modification of female cell division by altering the activation of CDKs in a tissue and temporal specific manner should increase the likelihood of vigorous female floral development and also improve the consistency of seed set under unfavorable conditions.
- the invention contemplates expression of cell division enhancing nucleotide sequences during vulnerable periods, primarily those involved with anthesis development, where yield is most significantly affected by stress.
- anthesis development shall include any period in plant development where yield may be more significantly impacted by stress. This can include the exponential growth phase of the ear during which biomass is accumulated and the lag phase of kernel development as more fully described herein and in the following references.
- ears shall not be limited to maize and shall include any developing female inflorescence from a plant.
- kernel shall also not be limited to maize but shall include grain, or seed within a fruit.
- cell division enhancing nucleotide sequence shall mean any nucleotide sequence, (DNA, RNA, coding and/or antisense) the expression of which increases the rate of a particular plant tissue's cell division as compared to the rate without the expression of said sequence.
- a genetic construct which causes expression of the cell division enhancing nucleotide sequence at a time and location to maximize cell division typically during very vulnerable periods primarily, around anthesis.
- the spatial and temporal expression of genes affecting cell division of tissues can be achieved using different types of promoters.
- Promoters useful for the invention are promoters which would cause the temporal and spatial expression of a gene product during anthesis as defined herein and can be constitutive, inducible, or tissue specific.
- seed specific promoters can be used to enhance cell division during seed development, pre-pollination promoters can also be used or stress inducible promoters can be used to enhance cell division during periods of stress.
- the optimization of promoters to achieve the objectives of the invention is considered routine and easily ascertainable by those of skill in the art and is intended to be within the scope of the invention.
- Figure 1 is a schematic diagram (reproduced from Shaw, Robert "Climate Requirement", Corn Improvement, 3 rd ed., Chapter 10, pp. 609-638). As shown in Figure 1, reprinted from Corn and Corn Improvement from p. 614) of the relationship between age of crop and percentage yield decrement due to 1 day of moisture stress. The top and bottom lines represent the highest and lowest yield reductions obtained in stress experiments, the middle line the average reduction.
- Figure 2 is a chart depicting expression timing of various promoters useful for the present invention.
- the present invention is based on isolation and characterization of genes affecting CDKs or enzymes which control CDKs which control cell division in plants.
- Any nucleotide sequence encoding an enzyme in the CDK activation/modulation (phosphorylation/dephosphorylation) pathways may be used in accordance with the present invention. Nucleotide sequences encoding these enzymes are easily ascertainable to those of skill in the art through Genbank or the references disclosed herein. Other reactions and pathways may be utilized by different organs in a plant or by different plant species. By changing the levels or activity of a component in the activation/deactivation/modulation pathway, it is possible to affect the levels of cell division in the plant, plant organ, or plant tissue.
- CDKs have been identified in plants.
- cDNAs encoding functional homologs of cdc2 kinase have been isolated by reduced stringency hybridization or reverse transcription coupled polymerase chain reaction from a number of plant species, including pea (Feiler and Jacobs, 1990), alfalfa (Hirt et al., 1991, 1993), Arabidopsis (Ferreira et al., 1991; Hirayama et al., 1991), soybean (Miao et al., 1993), Antirrhinum (Fobert et al., 1994), and maize (Colasanti et al., 1991). ). Soni, R. et al., "A Family of Cyclin D Homologs from Plants Differentially Controlled by Growth Regulators and Containing the
- At least three different types of cyclins have been identified in plants: A- type homologs, B-type homologs, and D-type homologs (Renaudin, J-P et al.,
- A-type cyclins are broken down into three structural groups (Al, A2, and A3). Cyclin Al has been isolated from maize. (Renaudin et al., Table 1). B-type cyclins are broken down into two structural groups (Bl, and B2). Cyclins Bl and B2 have been isolated from maize. (Renaudin et al., Table 1). D-type cyclins contain three structural groups (Dl, D2, and D3).
- a number of cDNA sequences encoding plant mitotic cyclins with A- or B-type characteristics of having mixed A- and B-type features have been isolated from various species, including carrot (Hata et al., 1991), soybean (Hata et al., 1991), Arabidopsis (Hermerly et al., 1992; Day and Reddy, 1994), alfalfa (Hirt et al, 1992), Antirrhinum (Fobert et al, 1994) and maize (Redaudin et al, 1994; Sun, Y. et al, 1997, CycZmln from maize endosperm (GenBank #U66607), CycZmel, GenBank #U66608). Soni, R. et al, "A Family of Cyclin D Homologs from Plants Differentially Controlled by Growth Regulators and Containing the conserveed Retinoblastoma Protein Interaction Motif', The
- the invention comprises a nucleotide construct comprising a cell division enhancing nucleotide sequence, a regulatory promoter to regulate temporal tissue and spatial expression during anthesis development and termination sequences operably linked to said cell division enhancing sequence.
- a non-exclusive list of enzymes that might be candidates for such intervention include Mytl, Weel, Niml, CDC25, Plxl, CKIs, CAK, and cyclins.
- Identification of other polynucleotides which may be useful in the invention will typically be based on screening for procaryotic or eucaryotic organisms with altered levels of cell division using assays standard in the art and described herein.
- plant hormones such as cyktokinins
- polynucleotides useful in the invention can be formed from a variety of different polynucleotides (e.g., genomic or cDNA, RNA, synthetic oligonucleotides, and polynucleotides), as well as by a variety of different techniques.
- a polynucleotide is a sequence of either eukaryotic or prokaryotic synthetic invention.
- the invention comprises use of one or more nucleotide sequences which, when expressed together enhance reproductive cell division.
- the invention comprises a DNA sequence encoding B- or D-type cyclins, CDC2 ⁇ , Niml, and or Plxl capable of promoting cell division by activating or modulating the activity of CDKs in critical, stress sensitive periods of plant development.
- DNA sequence encoding for suppression of Weel capable of promoting cell division by modulating the activity of CDKS is provided for increasing yield, seed development, flowering or resistance to stress.
- the invention is not limited to any plant type and can be used for any crop or ornamental plant species for which it is desirable to increase yield.
- the methods of the invention may be applicable to any species of seed-bearing plant to enhance yield potential by affecting the cell division in seed tissue.
- the nucleotide constructs of the present invention will share similar elements, which are well known in the art of plant molecular biology.
- the DNA sequences of interest will preferably be operably linked (i.e., positioned to ensure the functioning of) to a promoter which allows the DNA to be transcribed (into an RNA transcript) and will comprise a vector which includes a replication system.
- the DNA sequence of interest will be of exogenous origin in an effort to prevent co- suppression of the endogenous genes.
- Promoters may be heterologous (i.e., not naturally operably linked to a DNA sequence from the same organism).
- Promoters useful for expression in plants are known in the art and can be inducible, constitutive, tissue-specific, derived from eukaryotes, prokaryotes, or viruses, or have various combinations of these characteristics.
- tissue-specific or developmentally regulated promoter is a DNA sequence which regulates the expression of a DNA sequence selectively in the cells/tissues of a plant critical to seed set and/or function and/or limits the expression of such a DNA sequence to the period of seed maturation in the plant.
- Any identifiable promoter may be used in the methods of the present invention which causes expression during anthesis development as defined herein. It may also be advantageous to use a stress inducible promoter to provide expression of the construct during periods of stress.
- Differential screening techniques can be used to isolate promoters expressed in developing female reproductive organs (kernels and/or immature ears) from around 14 days before pollination to approximately 12 days after pollination. Promoters predicted to operate in this manner include LTP2, gamma- zein, and ZAG2.
- Promoters preferred for the invention would be acceptably timed to 14 days before and 12 days after anthesis when both immature ear and mitotically active kernel are most susceptible to the stress. Promoters predicted to operate during these developmental stages include LTP2, MZE40, nucl and ZAG2.
- LTP2 promoter from Barley confers the specificity of aleurone expression. Pioneer researchers have shown that this promoter is also functional in maize. When fused with a GUS reporter gene, LTP2 promoter directed aleurone specific expression of GUS activity in maize kernels (Niu and Tome, unpublished).
- Aleurone is a single celled, out-most layer of endosperm that retains mitotic activity when the central region of endosperm ceased division and committed to endoreduplication. Therefore, LTP2 promoter will allow us to manipulate endosperm cell division when fused with cell division regulatory genes.
- Zag2 transcripts can be detected 5 days prior to pollination to 7 to 8 DAP, and directs expression in the carpel of developing female inflorescences and Ciml which is specific to the nucellus of developing maize kernels. Ciml transcript is detected 4 to 5 days before pollination to 6 to 8 DAP.
- Other useful promoters include any promoter which can be derived from a gene whose expression is maternally associated with developing female florets.
- Figure 2 also depicts the timing of various preferred promoters and kernel development.
- a construct useful for the present invention might include the maize B-cyclin gene operably linked to the ZAG2 promoter for expression of B- cyclin ⁇ 0 to 22 days after pollination.
- promoters which are seed or embryo specific and may be useful in the invention include patatin (potato tubers) (Rocha-Sosa, M. et al (1989) EMBO ⁇ L 8:23-29), convicilin, vicilin, and legumin (pea cotyledons) (Rerie, W.G., et al. (1991) Mol. Gen. Genet. 2 ⁇ 9:149-l ⁇ 7; Newbigin, E.J., et al (1990) Planta 180:461- 470; Higgins, T.J.V., et al. (1988) Plant. Mol. Biol.
- Promoters of seed-specific genes operably linked to heterologous coding regions in chimeric gene constructions maintain their temporal and spatial expression pattern in transgenic plants.
- Such examples include Arabidopsis thaliana 2S seed storage protein gene promoter to express enkephalin peptides in Arabidopsis and Brassica napus seeds (Vanderkerckhove et al, Bio/Technology 7:L929-932 (1989)), been lectin and bean ⁇ -phaseolin promoters to express luciferase (Riggs et al, Plant Sci. 63:47- ⁇ 7 (1989)), and wheat glutenin promoters to express chloramphenicol acetyl transferase (Colot et al, EMBO J 6:3559-3564 (1987)).
- any inducible promoter can be used in the instant invention to temporarily express a particular construct during reproductive development. See Ward et al. Plant Mol. Biol.22: 361-366 (1993).
- Exemplary inducible promoters include, but are not limited to, that from the ACE1 system which responds to copper (Mett et al PNAS 90: 4567-4 ⁇ 71 (1993)); In2 gene from maize which responds to benzenesulfonamide herbicide safeners (Hershey et al, Mol. Gen. Genetics 227: 229-237 (1991) and Gatz et al, Mol Gen. Genetics 243: 32-38 (1994)) or Tet repressor from TnlO (Gatz et al, Mol Gen.
- a particularly preferred inducible promoter is a promoter that responds to an inducing agent to which plants do not normally respond.
- An exemplary inducible promoter is the inducible promoter from a steroid hormone gene, the transcriptional activity of which is induced by a glucocorticosteroid hormone. Schena et al, Proc. Natl. Acad. Sci. U.S.A. 88: 0421 (1991).
- constitutive promoters include, but are not limited to, the promoters from plant viruses such as the 35S promoter from CaMV (Odell et al, Nature 313: 810-812 (1985) and the promoters from such genes as rice actin (McElroy et al, Plant Cell 2: 163-171 (1990)); ubiquitin (Christensen et al, Plant Mol. Biol 12: 619-632 (1989) and Christensen et al, Plant Mol Biol. 18: 67 ⁇ -689 (1992)): pEMU (Last et al, Theor. Appl. Genet. 81: ⁇ 81- ⁇ 88 (1991)); MAS
- the ALS promoter a Xbal/Ncol fragment ⁇ ' to the Brassica napus ALS3 structural gene (or a nucleotide sequence that has substantial sequence similarity to said Xbal/Ncol fragment), represents a particularly useful constitutive promoter. See PCT application WO96/30 ⁇ 30. Transport of protein produced by transgenes to a subcellular compartment such as the nucleus, chloroplast, vacuole, peroxisome, glyoxysome, cell wall or mitochondrion, or for secretion into the apoplast, is accomplished by means of operably linking the nucleotide sequence encoding a signal sequence to the 5' and or 3' region of a gene encoding the protein of interest.
- Targeting sequences at the 5' and/or 3' end of the structural gene may determine, during protein synthesis and processing, where the encoded protein is ultimately compartmentalized.
- the presence of a signal sequence directs a polypeptide to either an intracellular organelle or subcellular compartment or for secretion to the apoplast.
- Many signal sequences are known in the art.
- an expression vector contains (1) prokaryotic DNA elements encoding for a bacterial replication origin and an antibiotic resistance marker to provide for the growth and selection of the expression vector in a bacterial host; (2) DNA elements that control initiation of transcription, such as a promoter; (3) DNA elements that control the processing of transcripts such as transcription termination/polyadenylation sequences; and (4) a reporter gene.
- Useful reporter genes include ⁇ -glucuronidase, ⁇ -galactosidase, chloramphynical acetyltransferase, luciferase, kanamycin or the herbicide resistance genes PAT and BAR.
- the selectable marker gene is kanamyacin or the herbicide resistance genes PAT and BAR.
- the BAR or PAT gene is used with the selecting agent Bialaphos, and is used as a preferred selection marker gene for plant transformation (Spencer, et al. (1990) J. Thero. Appl'd Genetics 79:62 ⁇ -631). ( ⁇ ) The target or structural gene of interest.
- nptll neomycin phosphotransferase II
- nptll neomycin phosphotransferase II
- Another commonly used selectable marker gene is the hygromycin phosphotransferase gene which confers resistance to the antibiotic hygromycin. Vanden Elzen et al, Plant Mol. Biol, 5: 299 (1985).
- Additional selectable marker genes of bacterial origin that confer resistance to antibiotics include gentamycin acetyl transferase, streptomycin phosphotransferase, aminoglycoside- 3' -adenyl transferase, the bleomycin resistance determinant. Hayford et al, Plant Physiol. 86: 1216 (1988), Jones et al, Mol. Gen. Genet., 2K_- 86 (1987), Svab et al, Plant Mol. Biol. 14: 197 (1990), Hille et al, Plant Mol. Biol. 7: 111 (1986).
- Other selectable marker genes confer resistance to herbicides such as glyphosate, glufosinate or broxynil.
- marker genes for plant transformation require screening of presumptively transformed plant cells rather than direct genetic selection of transformed cells for resistance to a toxic substance such as an antibiotic. These genes are particularly useful to quantify or visualize the spatial pattern of expression of a gene in specific tissues and are frequently referred to as reporter genes because they can be fused to a gene or gene regulatory sequence for the investigation of gene expression. Commonly used genes for screening presumptively transformed cells include ⁇ -glucuronidase (GUS), ⁇ -galactosidase, luciferase and chloramphenicol acetyltransferase. Jefferson, R.A., Plant Mol Biol Rep. 5: 387 (1987)., Teeri et al, EMBO J.
- GUS ⁇ -glucuronidase
- luciferase luciferase
- chloramphenicol acetyltransferase chloramphenicol acetyltransferase.
- GFP Green Fluorescent Protein
- GFP and mutants of GFP may be used as screenable markers.
- Genes included in expression vectors must be driven by a nucleotide sequence comprising a regulatory element, for example, a promoter.
- a regulatory element for example, a promoter.
- Several types of promoters are now well-known in the transformation arts, as are other regulatory elements that can be used alone or in combination with promoters.
- Expression vectors containing genomic or synthetic fragments can be introduced into protoplast or into intact tissues or isolated cells. Preferably expression vectors are introduced into intact tissue.
- General methods of culturing plant tissues are provided, for example, by Maki, et al (Maki, et al. (1993) Procedures for Introducing Foreign DNA into Plants: In: Methods in Plant Molecular Biology & Biotechnology; Glich et al. eds. (CRC Press), pp. 67-88; Philips, et al (1988) Cell-Tissue Culture and In Vitro Manipulation. In Corn & Corn Improvement, 3rd ed. Sprague, et al. eds. (American Society of Agronomy Inc.), pp. 34 ⁇ -387).
- Methods of introducing expression vectors into plant tissue include the direct transfection or co-cultivation of plant cell with Agrobacterium tumefaciens (Horsch et al. (198 ⁇ ) Science, 227:1229). Descriptions oi Agrobacterium vector systems and methods for Agrob ⁇ cte um-mediated gene transfer are provided by Gruber et al (supra).
- A. tumefaciens and A. rhizogenes are plant pathogenic soil bacteria which genetically transform plant cells.
- the Ti and Ri plasmids of A. tumefaciens and A. rhizogenes, respectively, carry genes responsible for genetic transformation of the plant. See, for example, Kado, C.I., Crit. Rev. Plant. Sci.10: 1 (1991).
- the expression vector is introduced into plant tissues with a biolistic device that accelerates the microprojectiles to speeds of 300 to 600 m/s which is sufficient to penetrate plant cell walls and membranes.
- a biolistic device that accelerates the microprojectiles to speeds of 300 to 600 m/s which is sufficient to penetrate plant cell walls and membranes.
- Transformed plants can be screened by biochemical, molecular biological, and other assays.
- Various assays may be used to determine whether a particular plant, plant part, or a transformed cell shows an increase in enzyme activity.
- the change in expression or activity of a transformed plant will be compared to levels found in wild type (e.g., untransformed) plants of the same type.
- the effect of the introduced construct on the level of expression or activity of the endogenous gene will be established from a comparison of sibling plants with and without the construct.
- Cyclin, CDC25, Niml, and Plxl transcript levels can be measured, for example, by Northern blotting, primer extension, quantitative or semi-quantitative PCR (polymerase chain reaction), and other methods well known in the art (See, e.g.,
- Protein can be measured in a number of ways including immunological methods (e.g., by Elisa or Western blotting).
- CDK activity can be measured in various assays as described in Sun et al, Proc. Nat'l. Acad. Sci. U S A. 96(7):4180-85 (1999).
- Cell division of a plant cell or tissue can be measured in a variety of ways including those described in Myers et al, Plant Physiol. 94:1330-36 (1990) and Artlip, et al, Plant Cell and Environ 18:1034-40 (1995).
- regeneration means growing a whole plant from a plant cell, a group of plant cells, a plant part, or a plant piece (e.g., from a protoplast, callus, or a tissue part).
- the foregoing methods for transformation would typically be used for producing transgenic inbred lines.
- Transgenic inbred lines could then be crossed, with another (non-transformed or transformed) inbred line, in order to produce a transgenic hybrid maize plant.
- a genetic trait which has been engineered into a particular maize line using the foregoing transformation techniques could be moved into another line using traditional backcrossing techniques that are well known in the plant breeding arts.
- a backcrossing approach could be used to move an engineered trait from a public, non-elite line into an elite line, or from a hybrid maize plant containing a foreign gene in its genome into a line or lines which do not contain that gene.
- crossing can refer to a simple X by Y cross, or the process of backcrossing, depending on the context.
- Various plants will be suitable targets for enhancing cell division in female reproductive organs with the identified genes.
- the methods of the invention described herein may be applicable to any crop species including but not limited to barley, sorghum, wheat, maize, soybean, and rice.
- transformation is carried out in maize plants according to the method of Agrobacterium.
- Parts obtained from the regenerated plant such as flowers, pods, seeds, leaves, branches, fruit, and the like, are covered by the invention, provided that these parts comprise cells which have been so transformed. Progeny and variants, and mutants of the regenerated plants are also included within the scope of this invention, provided that these parts comprise the introduced DNA sequences. Cyclin, CDC25, Niml,and Plxl levels and the activity of CDK are preferably determined as set forth in the examples.
- transgenic plant Once a transgenic plant is produced having a desired characteristic, it will be useful to propagate the plant and, in some cases, to cross to inbred lines to produce useful hybrids.
- mature transgenic plants may be self crossed to produce a homozygous inbred plant.
- the inbred plant produces seed containing the genes for the newly introduced trait. These seeds can be grown to produce plants that will produce the selected phenotype. All articles cited herein and in the following list are hereby expressly incorporated in their entirety by reference.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Cette invention se rapporte à un procédé transgénique servant à accroître la division cellulaire dans des organes reproducteurs femelles de plantes. Les gènes sont exprimés temporairement et spatialement pour modifier l'activation et/ou la modulation des kinases dépendantes de la cycline dans un organe ou un tissu végétal. Cette invention concerne également des produits d'expression et des procédés servant dans la production de plantes de culture ayant des phénotypes héritables qui sont utiles pour des programmes d'amélioration génétique conçus pour accroître le potentiel de rendement dans un large éventail de conditions ambiantes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15622299P | 1999-09-27 | 1999-09-27 | |
US156222P | 1999-09-27 | ||
PCT/US2000/026405 WO2001023594A2 (fr) | 1999-09-27 | 2000-09-26 | Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1220936A2 true EP1220936A2 (fr) | 2002-07-10 |
Family
ID=22558642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00965435A Withdrawn EP1220936A2 (fr) | 1999-09-27 | 2000-09-26 | Amelioration de la tolerance au stress dans le mais par manipulation des genes de regulation du cycle cellulaire |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1220936A2 (fr) |
AU (1) | AU780301B2 (fr) |
CA (1) | CA2374431A1 (fr) |
HU (1) | HUP0202626A3 (fr) |
MX (1) | MXPA02003254A (fr) |
WO (1) | WO2001023594A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015181823A1 (fr) * | 2014-05-28 | 2015-12-03 | Evogene Ltd. | Polynucléotides isolés, polypeptides et procédés de leur utilisation pour augmenter la tolérance au stress abiotique, de la biomasse et le rendement de végétaux |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2069507B1 (fr) * | 2007-01-31 | 2014-06-04 | BASF Plant Science GmbH | Plantes ayant des caracteristiques associees a un rendement ameliore et/ou a une resistance au stress abiotique augmentee, et leur procede de fabrication |
US9057074B2 (en) | 2008-03-25 | 2015-06-16 | Biogemma | Pedicel specific promoter |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE331797T1 (de) * | 1990-11-29 | 2006-07-15 | Cropdesign Nv | Kontrolle von pflanzenzellvermehrung und - wachstum |
GB9126818D0 (en) * | 1991-12-18 | 1992-02-19 | Ici Plc | Alteration of plant and plant cell morphology |
US5689042A (en) * | 1995-03-29 | 1997-11-18 | Wisconsin Alumni Research Foundation | Transgenic plants with altered senescence characteristics |
US6252139B1 (en) * | 1996-07-18 | 2001-06-26 | The Salk Institute For Biological Studies | Method of increasing growth and yield in plants |
US6465718B1 (en) * | 1997-03-14 | 2002-10-15 | Cropdesign N.V. | Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
EA003425B1 (ru) * | 1997-03-26 | 2003-04-24 | Кембридж Юниверсити Текникал Сервисиз Лимитед | Химерный ген, обеспечивающий экспрессию в растениях циклина d-типа, и способ получения растений с измененными ростовыми свойствами при использовании указанного гена |
WO1999022002A1 (fr) * | 1997-10-24 | 1999-05-06 | Cropdesign N.V. | Nouveau cycline mitogene et son utilisation |
AU3103599A (en) * | 1998-03-23 | 1999-10-18 | E.I. Du Pont De Nemours And Company | Plant cell cyclin genes |
WO1999053075A2 (fr) * | 1998-04-09 | 1999-10-21 | E.I. Du Pont De Nemours And Company | Proteines de regulation du cycle cellulaire cdc-16, dp-1, dp-2 et e2f tirees de plantes |
CA2326689A1 (fr) * | 1998-04-21 | 1999-10-28 | Cropdesign N.V. | Vegetaux tolerants aux agressions |
US6518487B1 (en) * | 1998-09-23 | 2003-02-11 | Pioneer Hi-Bred International, Inc. | Cyclin D polynucleotides, polypeptides and uses thereof |
US6777590B2 (en) * | 1998-12-23 | 2004-08-17 | Pioneer Hi-Bred International, Inc. | Cell cycle nucleic acids, polypeptides and uses thereof |
CA2263067A1 (fr) * | 1999-02-26 | 2000-08-26 | The Australian National University | Methode pour modifier la morphologie, la biochimie et la physiologie des plantes |
AU2786000A (en) * | 1999-02-26 | 2000-09-21 | Cropdesign N.V. | Method of modifying plant morphology, biochemistry or physiology using cdc25 substrates |
AU4396000A (en) * | 1999-03-19 | 2000-10-09 | Cropdesign N.V. | Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture |
MXPA01010439A (es) * | 1999-04-16 | 2003-09-10 | Pioneer Hi Bred Int | Expresion regulada de genes en semillas. |
AU5756800A (en) * | 1999-06-21 | 2001-01-09 | Pioneer Hi-Bred International, Inc. | Enhanced floral sink strength and increased stability of seed set in plants |
-
2000
- 2000-09-26 AU AU76155/00A patent/AU780301B2/en not_active Ceased
- 2000-09-26 CA CA002374431A patent/CA2374431A1/fr not_active Abandoned
- 2000-09-26 HU HU0202626A patent/HUP0202626A3/hu unknown
- 2000-09-26 EP EP00965435A patent/EP1220936A2/fr not_active Withdrawn
- 2000-09-26 WO PCT/US2000/026405 patent/WO2001023594A2/fr not_active Application Discontinuation
- 2000-09-26 MX MXPA02003254A patent/MXPA02003254A/es unknown
Non-Patent Citations (1)
Title |
---|
See references of WO0123594A2 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015181823A1 (fr) * | 2014-05-28 | 2015-12-03 | Evogene Ltd. | Polynucléotides isolés, polypeptides et procédés de leur utilisation pour augmenter la tolérance au stress abiotique, de la biomasse et le rendement de végétaux |
US10975383B2 (en) | 2014-05-28 | 2021-04-13 | Evogene Ltd. | Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
Also Published As
Publication number | Publication date |
---|---|
HUP0202626A2 (hu) | 2002-12-28 |
HUP0202626A3 (en) | 2004-09-28 |
WO2001023594A2 (fr) | 2001-04-05 |
AU780301B2 (en) | 2005-03-17 |
WO2001023594A3 (fr) | 2001-12-06 |
CA2374431A1 (fr) | 2001-04-05 |
AU7615500A (en) | 2001-04-30 |
MXPA02003254A (es) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7897843B2 (en) | Transcriptional regulation of plant biomass and abiotic stress tolerance | |
EP1546336B1 (fr) | Polynucleotides et polypeptides chez des plantes | |
EP1682668B1 (fr) | Regulateurs transcriptionnels de plantes | |
US20050086718A1 (en) | Plant transcriptional regulators of abiotic stress | |
US20090205063A1 (en) | Plant polynucleotides for improved yield and quality | |
US20090241218A1 (en) | Plants having enhanced yield-related traits and a method for making the same | |
US20040128712A1 (en) | Methods for modifying plant biomass and abiotic stress | |
US20090265813A1 (en) | Stress tolerance in plants | |
US8283519B2 (en) | Plant transcriptional regulators of abiotic stress | |
US20090083877A1 (en) | Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance | |
US20050155117A1 (en) | Transcriptional regulation of plant disease tolerance | |
EP1456379A2 (fr) | Compositions et procedes de modulation du developpement de plantes | |
US20110138499A1 (en) | Plant quality traits | |
EP1002087B1 (fr) | Procede permettant d'augmenter la taille d'un fruit dans une plante | |
US8026411B2 (en) | Enhanced floral sink strength and increased stability of seed set in plants | |
US20060191040A1 (en) | Nucleotide sequences encoding RAMOSA3 and sister of RAMOSA3 and methods of use for same | |
AU780301B2 (en) | Enhanced stress tolerance in maize via manipulation of cell cycle regulatory genes | |
US6828478B2 (en) | Combinations of genes for producing seed plants exhibiting modulated reproductive development | |
WO2001090343A2 (fr) | Sequences nucleotidiques codant pour le gene ramosa 1 et methode d'utilisation de ces sequences nucleotidiques | |
US20130031669A1 (en) | Plant transcriptional regulators of abiotic stress ii | |
AU2002305492A1 (en) | Combinations of genes for producing seed plants exhibiting modulated reproductive development | |
US20140201861A1 (en) | Polynucleotides and polypeptides that confer increased yield, size or biomass |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020402 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
17Q | First examination report despatched |
Effective date: 20031211 |
|
17Q | First examination report despatched |
Effective date: 20031211 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070401 |